Andersons, Inc.
ANDE- Exchange
- Nasdaq
- Industry
- Wholesale-Farm Product Raw Materials
- SEC CIK
- 0000821026
No open-market purchases or sales by Andersons, Inc. insiders were filed in the last 90 days; 304 institutions reported holding it in 13F filings for Q2 2026, worth $2.08B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:07 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 18, 2025 | Feb 20, 2024 | Feb 14, 2023 | Feb 15, 2022 |
| Revenue | $11.0B | $11.3B | $14.8B | $17.3B | $12.6B |
| Cost of revenue | $10.3B | $10.6B | $14.0B | $16.6B | $12.0B |
| Gross profit | $713.7M | $693.9M | $745.4M | $684.2M | $592.7M |
| Income tax | $22.2M | $30.1M | $37.0M | $39.6M | $29.2M |
| Net income | $95.7M | $114.0M | $101.2M | $131.1M | $104.0M |
| EPS, basic | – | $3.35 | $3.00 | $3.89 | $3.12 |
| EPS, diluted | – | $3.32 | $2.94 | $3.81 | $3.07 |
| Weighted shares, basic | 34.0M | 34.0M | 33.7M | 33.7M | 33.3M |
| Weighted shares, diluted | 34.3M | 34.3M | 34.4M | 34.4M | 33.9M |
| Margins and growth | |||||
| Gross margin | 6.5% | 6.2% | 5.1% | 3.9% | 4.7% |
| Net margin | 0.9% | 1.0% | 0.7% | 0.8% | 0.8% |
| Revenue growth, year over year | −2.2% | −23.7% | −14.9% | +37.4% | +53.6% |
| Net income growth, year over year | −16.1% | +12.7% | −22.8% | +26.1% | +1,248.7% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 18, 2025 | Feb 20, 2024 | Feb 14, 2023 | Feb 15, 2022 |
| Cash and equivalents | $98.3M | $561.8M | $643.9M | $115.3M | $216.4M |
| Inventory | $1.37B | $1.29B | $1.17B | $1.73B | $1.81B |
| Total current assets | $2.38B | $2.85B | $2.81B | $3.47B | $3.37B |
| Property, plant and equipment | $939.5M | $868.2M | $693.4M | $762.7M | $786.0M |
| Goodwill | $127.9M | $127.9M | $127.9M | $129.3M | $129.3M |
| Intangible assets | $63.5M | $69.3M | $85.6M | $100.9M | $117.1M |
| Total assets | $3.71B | $4.12B | $3.86B | $4.61B | $4.57B |
| Short-term debt | $63.4M | $36.1M | $27.6M | $272.6M | $501.8M |
| Total current liabilities | $1.69B | $1.73B | $1.64B | $2.52B | $2.46B |
| Long-term debt | $560.0M | $608.2M | $563.0M | $492.5M | $600.5M |
| Total liabilities | $2.42B | $2.52B | $2.34B | $3.18B | $3.26B |
| Shareholders' equity | $1.29B | $1.60B | $1.52B | $1.43B | $1.31B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 18, 2025 | Feb 20, 2024 | Feb 14, 2023 | Feb 15, 2022 |
| Operating cash flow | $177.0M | $331.5M | $946.8M | $287.1M | -$51.0M |
| Capital expenditures | $233.1M | $149.2M | $150.4M | $108.3M | $75.8M |
| Free cash flow | -$56.1M | $182.3M | $796.3M | $178.8M | -$126.8M |
| Depreciation and amortization | $133.3M | $127.8M | $125.1M | $134.7M | $178.9M |
| Stock-based compensation | $17.0M | $13.6M | $12.9M | $11.2M | $11.0M |
| Dividends paid | $26.8M | $26.3M | $25.4M | $24.6M | $23.7M |
| Share buybacks | $15.4M | $2.29M | $1.75M | $12.7M | – |
| Investing cash flow | -$195.3M | -$163.1M | -$153.9M | -$52.9M | $487.2M |
| Financing cash flow | -$447.1M | -$250.4M | -$264.0M | -$334.7M | -$248.8M |
| Net change in cash | -$463.5M | -$82.1M | $528.6M | -$101.2M | $187.3M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.